Hepatocellular carcinoma
Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Richard S. Finn(University of California, Los Angeles), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Kazuhiko Koike(Kanto Central Hospital), Riccardo Lencioni(University of Pisa), Jessica Zucman‐Rossi(Inserm), Augusto Villanueva(NYU Langone Health), Eli Pikarsky(Hadassah Medical Center), Sasan Roayaie(White Plains Hospital), Amit G. Singal(Southwestern Medical Center)
Cited by 6,635
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k